Phase III KEYNOTE-177 Study of Pembrolizumab Doubles PFS in MSI-H/dMMR mCRC
Front-line therapy with pembrolizumab doubled progression-free survival versus chemotherapy in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Osimertinib Improves Disease-Free Survival in Patients with EGFR-Mutated Advanced NSCLC
Phase III data, presented at the 2020 ASCO Virtual Scientific Program, showed that treatment with osimertinib dramatically improved disease-free survival compared to placebo for patients with EGFR-mutated advanced NSCLC. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Study Finds Increased Risk for Death Following Chemo Use in Patients with Thoracic Cancer, COVID-19
Chemotherapy use in patients with lung and other thoracic cancers who are also diagnosed with COVID-19 was found to be associated with an increased risk of death compared to other treatment methods. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Jessica Skarzynski Source Type: news
Cancer Progression Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis
Disease progression and treatment with hydroxychloroquine and azithromycin were associated with increased all-cause 30-day mortality in patients with cancer compared to patients either in remission or with no evidence of disease, according to data presented during a 2020 ASCO Virtual Scientific Program press briefing. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Ryan McDonald Source Type: news
Avelumab Appears to be Effective in Preventing Relapse in Women With GTT
The phase II study was the first trial to explore the use of immunotherapy for patients who were resistant to standard chemotherapy treatment (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news
Addition of Avelumab to Best Supportive Care After Firstline Chemo Improves Survival in Advanced Urothelial Cancer
Immunotherapy with avelumab improved survival when given as maintenance therapy in patients whose disease did not progress on platinum-based chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Beth Fand Incollingo Source Type: news
H & amp;E Staining Deep Learning Models May Preserve Prostate Cancer Tissue Samples
Researchers detailed methods and processes that may be useful for additional research and validation of computational hematoxylin and eosin staining deep learning models and the images generated by them. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Stephen Schuster, MD, Gives Advice for Treating Aggressive Lymphomas During COVID-19 Pandemic
Stephen Schuster, MD, talked about the benefits of conducting routine visits remotely during the COVID-19 pandemic, allowing doctors to see and treat more patients safely and efficiently. (Source: CancerNetwork)
Source: CancerNetwork - May 28, 2020 Category: Cancer & Oncology Authors: Stephen Schuster, MD Source Type: news
FDA Approves Nivolumab Plus Ipilimumab with Chemotherapy for NSCLC
The FDA approved the use of nivolumab plus ipilimumab given with 2 cycles of platinum-doublet chemotherapy as a first-line treatment for adult patients with metastatic or recurrent non-small cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Follow-up 6 Months After BI-RADS 3 Findings on Mammography Recommended for Women
A study found that a 6-month follow-up examination was recommended for women found to have BI-RADS 3 lesions after previous recommendations suggested a year follow-up was safely sufficient. (Source: CancerNetwork)
Source: CancerNetwork - May 27, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Payment Models May be Associated with Fewer Visits, Lower Costs in Cancer Settings
Payment models with shared-savings components, such as the Oncology Care Model, may be associated with fewer visits and lower costs in certain cancer settings in the first year. (Source: CancerNetwork)
Source: CancerNetwork - May 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Judy Ou, PhD, on Fine Particulate Matter in Pediatric and AYA Patients with Cancer
The research scientist spoke about the study that found that fine particulate matter pollution was associated with mortality in pediatric, adolescent, and young adult patients with specific cancers. (Source: CancerNetwork)
Source: CancerNetwork - May 27, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Grants Fast Track Designation for CLR 131 in LPL/WM
The FDA granted fast track designation for CLR 131 in lymphoplasmacytic lymphoma/Waldenstrom ’s macroglobulinemia in patients having received 2 prior treatment regimens or more. (Source: CancerNetwork)
Source: CancerNetwork - May 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Families ’ Understanding of Adolescents Values Regarding EOL Care
Families of dying adolescents were found to have a poor understanding of their adolescent ’s values in terms of their own end-of-life care. (Source: CancerNetwork)
Source: CancerNetwork - May 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
New, Non-Invasive Blood Test Could Assist in Early Detection of Endometrial Cancer
Researchers from a study published in Cancers discovered a new method of detecting endometrial cancer in women via a simple, non-invasive blood test. (Source: CancerNetwork)
Source: CancerNetwork - May 26, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
